Filing Details
- Accession Number:
- 0001237899-12-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-02 15:15:04
- Reporting Period:
- 2012-03-01
- Filing Date:
- 2012-03-02
- Accepted Time:
- 2012-03-02 15:15:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174475 | S Michael Brown | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-01 | 4,374 | $19.69 | 19,036 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-01 | 4,374 | $102.65 | 14,662 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-03-01 | 626 | $19.69 | 15,288 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-01 | 626 | $103.01 | 14,662 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-03-01 | 5,000 | $15.80 | 19,662 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-01 | 5,000 | $103.06 | 14,662 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-03-01 | 7,300 | $19.69 | 21,962 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-01 | 7,300 | $103.39 | 14,662 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-03-01 | 2,700 | $19.69 | 17,362 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-01 | 2,700 | $104.32 | 14,662 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-01 | 5,000 | $0.00 | 5,000 | $15.80 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-01 | 4,374 | $0.00 | 4,374 | $19.69 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-01 | 626 | $0.00 | 626 | $19.69 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-01 | 7,300 | $0.00 | 7,300 | $19.69 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-01 | 2,700 | $0.00 | 2,700 | $19.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-01-03 | No | 4 | M | Direct | |
| 10,626 | 2017-01-03 | No | 4 | M | Direct | |
| 10,000 | 2017-01-03 | No | 4 | M | Direct | |
| 2,700 | 2017-01-03 | No | 4 | M | Direct | |
| 0 | 2017-01-03 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 4,374 shares of Company stock on March 1, 2012 at prices ranging from $102.42 to $102.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2012 at each separate price.
- Represents volume-weighted average price of sales of 626 shares of Company stock on March 1, 2012 at prices ranging from $103.00 to $103.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2012 at each separate price.
- Represents volume-weighted average price of sales of 5,000 shares of Company stock on March 1, 2012 at prices ranging from $103.02 to $103.15. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2012 at each separate price.
- Represents volume-weighted average price of sales of 7,300 shares of Company stock on March 1, 2012 at prices ranging from $103.15 to $103.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2012 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
